NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

Durham's Path BioAnalytics is teaming up with impact investors and a digital health company to find a cure for pancreatitis.
Advanced Animal Diagnostics is using a $50,000 grant from NCBiotech, through a program established by the Wells Fargo Foundation, to “repurpose” its blood test platform designed to detect disease in cattle, to add a screen for COVID-19 in humans.
“The future of biopharma is in females,” said Mycovia CEO Patrick Jordan earlier this week during a panel discussion at the BIO Digital life sciences conference.
NCBiotech provided a $250,000 loan to bootstrap CasTag BioSciences, a Duke spinout based on a technology that marks proteins in an entirely new way, using the genome-editing tool CRISPR. The resulting products are selling, and the potential is HiUGE.
Greensboro's Kepley BioSystems has developed a natural liquid called K9 Strategic Scent Stimulant to help dogs avoid distraction while you're socially distancing on COVID-era walks.
A LabCorp blood test that helps identify individuals who’ve been exposed to the COVID-19 coronavirus is now broadly available.
Audentes Therapeutics, a San Francisco company whose name changed to Astellas Gene Therapies on March 31, 2021, announced plans for a $109.4 million, 209-employee gene therapy production facility in Sanford, a short distance from a $600 million Pfizer gene therapy campus under construction.
Grifols, a global biotherapeutics company with major operations in North Carolina, has begun producing the first specific COVID-19 drug at its manufacturing campus in Clayton.
Raleigh's Collaborations Pharmaceuticals is partnering with universities, foundations and other companies to develop drugs that treat rare and neglected diseases, but it's also targeting COVID-19 now. 
Appalachian State University faculty members have developed a free app to allow people around the world log the activity of bees and other pollinators.
NC Med Tech Firm BioMedInnovations Gets FDA OK for Innovative COVID-19 Ventilator Developed wIth Rare Partnerships, from NASCAR to Lawrence Livermore
Grifols, a global biotherapeutics company with more than 2,000 employees in North Carolina, is adding 300 more to its Clayton workforce as part of a $351.6 million expansion there.
A transformative Belgian crop protection company, Biotalys NV, is establishing U.S. headquarters in Research Triangle Park.
Cary-based startup Atom Bioworks plans to use artificial intelligence and nanotechnology, boosted by a $240K NSF grant, to design a rapid diagnostic for COVID-19.
NCBiotech portfolio company Arrevus has landed two federal grants totaling roughly $800,000 to investigate its novel chaperone protein inhibitor, ARV-1502, ​for treating sepsis and for wound healing.
scroll back to top of page